Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-06

Clinical Trial Update: Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells [NA]

View source ↗

Summary

A completed clinical trial evaluating Spray-On Skin autologous epidermal cell suspension for repigmenting stable vitiligo lesions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spray-On Skin Cells (autologous epidermal cell suspension)

Snippet

Sponsor: Avita Medical | Conditions: Vitiligo | NA | Status: COMPLETED